The TGA has approval has nothing to do with the FDA, nor did I suggest it did. Your equally toxic and ignorant friend was incorrectly throwing around decade timelines in the usual FUD'ster from a company that IS NOT CYP. I showed said poster that whilst that company was hoping to have FDA IND's filed in the next five years, CYP filed its first FDA IND 8 years ago and was cleared 3 years ago.
Separately - whilst the company he referred to has no formal standalone phase anything trials ongoing or coming in IPSC's anytime soon - I reminded him CYP has a fully funded phase III fully recruited and is awaiting data/results and was given an expediated approval pathway by the TGA back in 2020, i.e. his poorly derived decade timeline was codswallop when it comes to CYP's commercial pathways "particularly in Australia". The separation between the two is clear....multiple times.
Ho on earth can you misread that? Its plain English.
You really must improve your reading skills, as your similar clear errors/falsehoods you have posted on CYP's ASX releases have shown (by more than me alone). Its a bore constantly correcting the misinformation your guys post on CYP, be it purposeful or in error - surely you cannot be that poor of reading, so probably the former.
Oh, and Sector is dead. Do get a life.
CYP Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)